LYELL IMMUNOPHARMA INC

CUSIP: 55083R104 Class: Common Stock

Ikarian Capital, LLC's Holding History (CIK: 0001778253)

Note: Option positions (PUT/CALL) are excluded.

Q1 2025
Shares 876,037 Value ($000) $471 Avg Close — Range —
Q4 2024
Shares 1,276,037 Value ($000) $817 Avg Close — Range —
Q3 2024
Shares 526,066 Value ($000) $726 Avg Close — Range —
Q2 2024
Shares 526,066 Value ($000) $763 Avg Close — Range —